Protective effects of early treatment with lipoic acid in LPS- induced lung injury in rats

Journal of Physiology and Pharmacology

Volumn 58, Issue 3, 2007, Pages 541-549

  Goraca A ^a,b   Jozefowicz Okonkwo G ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Department of Cardiovascular Physiology ^*  (Poland)

Author keywords

Antioxidants; Endotoxin; Oxidative stress

Indexed keywords

HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; LIPID PEROXIDATION; LUNG EDEMA; LUNG INJURY; LUNG WEIGHT; MALE; NONHUMAN; OBSERVATION; OXIDATIVE STRESS; RAT; SEPTIC SHOCK; SINGLE DRUG DOSE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; INJECTIONS, INTRAVENOUS; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LUNG; MALE; OXIDATIVE STRESS; PULMONARY EDEMA; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOCTIC ACID; TIME FACTORS;

EID: 34948818272     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tsuji C, Minhaz MU, Shioya S, Fukahori M, Tanigaki T, Nakazawa H. The importance of polymorphonuclear leucocytes in lipopolysaccharide-induced superoxide anion production and lung injury: ex vivo observation in rat lungs. Lung 1998; 176: 1-13.
2. Gȩbska A, Olszanecki R, Korbut R. Endotoxemia in rats. Role of leucocyte sequestration in rapid pulmonary nitric oxide synthetase-2-expression. J Physiol Pharmacol 2005; 56: 299-311.
3. Victor VM, Rocha M, De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. International Immunopharmacology 2004; 4: 327-347.
4. Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995; 35: 655-677.
5. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006; 160: 1-40.
6. Bilska A, Wlodek L. Lipoic acid-the drug of the future? Pharmacol Rep 2005; 57: 570-577.
7. Savitha S, Tamilselvan J, Anusuyadevi M, Panneerselvam Ch. Oxidative stress on mitochondrial antioxidant defense system in the aging process. Role of DL-α-lipoic acid and L-carnitine. Clinica Chimica Acta 2005; 355: 173-180.
8. Arvazhagan P, Panneerselvam SR, Panneerselvam C. Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and lipids in aged rats. J Gerontol A Biol Sci Med Sci 2003; 58: B788-B791.
9. Coleman MD, Eason RC, Bailey CJ. The therapeutic use of lipoic acid in diabetes: a current perspective. Env Tox Pharmacol 2001; 10: 167-172.
10. Suntres ZE. Prophylaxis against lipopolysaccharide-induced liver injuries by lipoic acid in rats. Pharmacological Res 2003; 48: 585-591.
11. Celik I, Cihangiroglu M, Ilhan N, Akpolat N, Akbulut HH. Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity. Basic and clinical Pharmacol and Toxicology 2005; 97: 325-332.
12. De Marco VG, Bosanquet JP, Rawlani VR, Skimming JW. Lipoic acid decreases exhaled nitric oxide concentrations in anesthetized endotoxemic rats. Vascul Pharmacol 2005; 43: 404-410.
13. Skibska B, Ciejka E, Goraca A. Estimation of the effect of lipoic acid in the rat's lung during lipopolysaccharide-induced oxidative stress. Pol Merkur Lekarski 2006; 20: 651-654.
14. Kasielski M, Nowak D. Long-term administration of N - acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001; 95: 448-456.
15. 2 production by macrophages and neurotrophils with homovanilic acid and horse-radish peroxidase. J Immunol Meth 1983; 63: 347-357.
16. Ellman GL. SH groups determination in biological fluids. Anal Biochem 1970; 46: 237.
17. Rahman I, Biswas S, Kode A. Oxidant and antioxidant balance in the airways and airway disease. Eur J Pharmacol 2006; 533: 222-239.
18. Olszanecki R, Gȩbska A, Jawien J, Jakubowski A, Korbut R. Inhibition of NOS-2 induction in LPS-stimulated J 774.2 cells by 1,5 -isoquinolinediol an inhibitor of PARP. J Physiol Pharmacol 2006; 57: 109-117.
19. Planas M, Garcia A. Lipid peroxidation in critical patients. Nutr Hosp 1997; 12: 233-236.
20. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1998; 26: 705-709.
21. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997; 47: 1209-1214.
22. Hewett JA, Roth RA. Hepatic and extrahepatic pathology of bacterial lipopolysaccharides. Pharmacol Rev 1993; 45: 381-411.
23. Gonzalez-Perez O, Gonzalez Castaneda RE. Therapeutic perspectives on the combination of alpha-lipoic acid and vitamin E. Nutrition Research 2006; 26: 1-5.
24. Terjesen BF, Park K, Tesser MB, Portella MC, Zhang Y, Dabrowski K. Lipoic acid and ascorbic acid effect plasma free amino acids selectivity in the teleost fish Pacu (Piaractus mesopotamicus). Biochem Molecular Actions Nutrients 2004; 134: 2930-2939.
25. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-250.
26. Han D, Handelman G, Mrcocci L, et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cysteine utilization. Biofactors 1997; 6: 321-338.